Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (GB:0A2V)
LSE:0A2V
Sanofi (0A2V) Share Forecast & Price Target
3 Followers
See the Price Targets and Ratings of:
0A2V Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0A2V Stock 12 Month Forecast
There Are No Analyst Ratings for GB:0A2V In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
0A2V Financial Forecast
Detailed List of Analyst Forecasts
Morgan Stanley
―
Hold
―
Reiterated
02/01/24
Sanofi (SNY) shares slide following Q4 revenue missMorgan Stanleys Mark Purcell kept an Equal-Weight rating on SNY, saying they expect Sanofi shares to be broadly flat to slightly down, "with a small miss on 4Q23 Q23 expectations and FY24 guidance implying a small FX-based cut to consensus.
Citi
―
Buy
―
Reiterated
02/01/24
Sanofi (SNY) shares slide following Q4 revenue missReacting to the report, Citi analyst Peter Verdult said the underlying story is unchanged for the company.
Jefferies
$63.00
Buy
28.17%
Upside
Reiterated
01/16/24
Sanofi price target lowered to $63 from $64 at JefferiesSanofi price target lowered to $63 from $64 at Jefferies
Berenberg Bank
$123.48
Buy
151.21%
Upside
Reiterated
10/05/23
Sanofi's Strategic Partnerships and Pipeline Expansion Drive Buy Rating: An Analysis by Luisa Hector
Best Analysts Covering Sanofi
Which Analyst Should I Follow If I Want to Buy GB:0A2V and Sell After:
1 Month
3 Months
1 Year
Success Rate
4/5 ratings generated profit
Average Return
+2.70%
reiterated a buy rating 7 months ago
Copying Luisa Hector's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +2.70% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0A2V Analyst Recommendation Trends
Rating
Oct 23
Nov 23
Dec 23
Jan 24
Feb 24
Strong Buy
1
1
1
0
0
Buy
6
4
1
2
2
Hold
0
0
1
2
3
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
8
6
3
4
5
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
0A2V Stock Forecast FAQ
What is GB:0A2V’s average 12-month price target, according to analysts?
Currently, no data Available
What is GB:0A2V’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0A2V, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sanofi a Buy, Sell or Hold?
Currently, no data Available
What is Sanofi’s share price target?
Currently, no data Available
What do analysts say about Sanofi?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Sanofi?
To buy shares of GB:0A2V, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.